OCI NV (OCI.AS) Stock Fundamental Analysis

AMS:OCI • NL0010558797

3.472 EUR
-0.01 (-0.23%)
Last: Feb 20, 2026, 07:00 PM
Fundamental Rating

4

Taking everything into account, OCI scores 4 out of 10 in our fundamental rating. OCI was compared to 66 industry peers in the Chemicals industry. There are concerns on the financial health of OCI while its profitability can be described as average. OCI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • OCI had positive earnings in the past year.
  • OCI had a negative operating cash flow in the past year.
  • In multiple years OCI reported negative net income over the last 5 years.
  • OCI had a positive operating cash flow in each of the past 5 years.
OCI.AS Yearly Net Income VS EBIT VS OCF VS FCFOCI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

  • OCI's Return On Assets of 140.76% is amongst the best of the industry. OCI outperforms 100.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 267.17%, OCI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 140.76%
ROE 267.17%
ROIC N/A
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
OCI.AS Yearly ROA, ROE, ROICOCI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

  • OCI's Profit Margin of 510.59% is amongst the best of the industry. OCI outperforms 100.00% of its industry peers.
  • In the last couple of years the Profit Margin of OCI has grown nicely.
  • The Gross Margin of OCI (0.21%) is worse than 86.36% of its industry peers.
  • In the last couple of years the Gross Margin of OCI has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 510.59%
GM 0.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
OCI.AS Yearly Profit, Operating, Gross MarginsOCI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

3

2. Health

2.1 Basic Checks

  • OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OCI remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, OCI has more shares outstanding
  • Compared to 1 year ago, OCI has an improved debt to assets ratio.
OCI.AS Yearly Shares OutstandingOCI.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OCI.AS Yearly Total Debt VS Total AssetsOCI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • OCI has an Altman-Z score of 0.91. This is a bad value and indicates that OCI is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.91, OCI is not doing good in the industry: 78.79% of the companies in the same industry are doing better.
  • OCI has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.05, OCI belongs to the top of the industry, outperforming 87.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACCN/A
WACC8.19%
OCI.AS Yearly LT Debt VS Equity VS FCFOCI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • OCI has a Current Ratio of 1.65. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
  • OCI's Current ratio of 1.65 is in line compared to the rest of the industry. OCI outperforms 50.00% of its industry peers.
  • OCI has a Quick Ratio of 1.61. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
  • OCI's Quick ratio of 1.61 is fine compared to the rest of the industry. OCI outperforms 74.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.61
OCI.AS Yearly Current Assets VS Current LiabilitesOCI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 1368.28% over the past year.
  • The Earnings Per Share has been growing by 105.88% on average over the past years. This is a very strong growth
  • OCI shows a small growth in Revenue. In the last year, the Revenue has grown by 3.00%.
  • Measured over the past years, OCI shows a very negative growth in Revenue. The Revenue has been decreasing by -20.30% on average per year.
EPS 1Y (TTM)1368.28%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%3950%
Revenue 1Y (TTM)3%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-53.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 60.21% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, OCI will show a very negative growth in Revenue. The Revenue will decrease by -14.70% on average per year.
EPS Next Y1314.85%
EPS Next 2Y177.01%
EPS Next 3Y11.85%
EPS Next 5Y60.21%
Revenue Next Year-32.7%
Revenue Next 2Y-18.52%
Revenue Next 3Y-27.35%
Revenue Next 5Y-14.7%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OCI.AS Yearly Revenue VS EstimatesOCI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
OCI.AS Yearly EPS VS EstimatesOCI.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 0.17, which indicates a rather cheap valuation of OCI.
  • OCI's Price/Earnings ratio is rather cheap when compared to the industry. OCI is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, OCI is valued rather cheaply.
  • A Price/Forward Earnings ratio of 10.88 indicates a reasonable valuation of OCI.
  • OCI's Price/Forward Earnings ratio is rather cheap when compared to the industry. OCI is cheaper than 95.45% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, OCI is valued rather cheaply.
Industry RankSector Rank
PE 0.17
Fwd PE 10.88
OCI.AS Price Earnings VS Forward Price EarningsOCI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCI.AS Per share dataOCI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • OCI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y177.01%
EPS Next 3Y11.85%

0

5. Dividend

5.1 Amount

  • No dividends for OCI!.
Industry RankSector Rank
Dividend Yield 0%

OCI NV

AMS:OCI (2/20/2026, 7:00:00 PM)

3.472

-0.01 (-0.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-13
Earnings (Next)03-12
Inst Owners41.28%
Inst Owner ChangeN/A
Ins Owners8.46%
Ins Owner ChangeN/A
Market Cap733.84M
Revenue(TTM)975.10M
Net Income(TTM)4.98B
Analysts69.09
Price Target3.89 (12.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend12.95
Dividend Growth(5Y)N/A
DP84.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-44.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)103.03%
EPS NY rev (3m)86.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.4%
Valuation
Industry RankSector Rank
PE 0.17
Fwd PE 10.88
P/S 0.88
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)20.07
EY578.05%
EPS(NY)0.32
Fwd EY9.19%
FCF(TTM)-1.06
FCFYN/A
OCF(TTM)-1.64
OCFYN/A
SpS3.93
BVpS7.5
TBVpS7.41
PEG (NY)0
PEG (5Y)N/A
Graham Number58.2
Profitability
Industry RankSector Rank
ROA 140.76%
ROE 267.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 510.59%
GM 0.21%
FCFM N/A
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 241.89%
Cap/Sales 14.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.61
Altman-Z 0.91
F-Score4
WACC8.19%
ROIC/WACCN/A
Cap/Depr(3y)137.7%
Cap/Depr(5y)97.09%
Cap/Sales(3y)24.99%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1368.28%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%3950%
EPS Next Y1314.85%
EPS Next 2Y177.01%
EPS Next 3Y11.85%
EPS Next 5Y60.21%
Revenue 1Y (TTM)3%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-53.2%
Revenue Next Year-32.7%
Revenue Next 2Y-18.52%
Revenue Next 3Y-27.35%
Revenue Next 5Y-14.7%
EBIT growth 1Y44.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.34%
EBIT Next 3Y-24.1%
EBIT Next 5Y-4.61%
FCF growth 1Y-119.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.07%
OCF growth 3Y-68.9%
OCF growth 5Y-27.39%

OCI NV / OCI.AS FAQ

What is the ChartMill fundamental rating of OCI NV (OCI.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to OCI.AS.


Can you provide the valuation status for OCI NV?

ChartMill assigns a valuation rating of 6 / 10 to OCI NV (OCI.AS). This can be considered as Fairly Valued.


What is the profitability of OCI stock?

OCI NV (OCI.AS) has a profitability rating of 4 / 10.


Can you provide the financial health for OCI stock?

The financial health rating of OCI NV (OCI.AS) is 3 / 10.


How sustainable is the dividend of OCI NV (OCI.AS) stock?

The dividend rating of OCI NV (OCI.AS) is 0 / 10 and the dividend payout ratio is 84.62%.